181 related articles for article (PubMed ID: 27155152)
1. High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.
Zhang Z; Huang S; Wang H; Wu J; Chen D; Peng B; Zhou Q
Biochem Biophys Res Commun; 2016 Jun; 474(4):673-679. PubMed ID: 27155152
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
Zhao F; Gong X; Liu A; Lv X; Hu B; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1136-1143. PubMed ID: 29175326
[TBL] [Abstract][Full Text] [Related]
3. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
4. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
Hu BS; Xiong SM; Li G; Li JP
Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
[TBL] [Abstract][Full Text] [Related]
6. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.
Li C; Liao J; Wu S; Fan J; Peng Z; Wang Z
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):511-517. PubMed ID: 29106957
[TBL] [Abstract][Full Text] [Related]
8. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
13. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J
Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
[TBL] [Abstract][Full Text] [Related]
16. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
17. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
18. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
[TBL] [Abstract][Full Text] [Related]
19. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]